PRRT Therapy (Peptide Receptor Radionuclide Therapy) is an advanced targeted cancer treatment used for neuroendocrine tumors (NETs).
This innovative Lutetium-177 (Lu-177) therapy delivers radiation directly to tumor cells, helping control tumor growth and improve patient outcomes.
Consult our expert in Delhi for personalized PRRT therapy.
PRRT Therapy is a specialized nuclear medicine treatment where a radioactive peptide binds to tumor cells and delivers targeted radiation.
It is highly effective for tumors that express somatostatin receptors.
A peptide binds to tumor receptors.
Lutetium-177 delivers radiation directly to tumor cells.
Cancer cells are destroyed internally.
Minimal impact on healthy tissues.
PRRT therapy in Delhi is recommended for:
Take the next step toward advanced neuroendocrine tumor treatment in Delhi.
Precisely targets neuroendocrine tumor cells.
Works well in advanced-stage neuroendocrine tumors.
Helps reduce symptoms and enhances comfort.
Safer and better tolerated than chemotherapy.
Helps slow down or stop tumor growth.
The cost depends on:
For accurate pricing, book a consultation in Delhi.
Book ConsultationPRRT therapy is generally safe, but mild side effects may include:
Side effects are manageable with proper care.
PRRT is commonly performed using Lutetium-177 (Lu-177), making it a powerful form of radiopharmaceutical therapy.
It ensures precision targeting and better treatment outcomes.
